Coronavirus Update: AZ Gets $1bn From US, Secures Capacity For One Billion Vaccine Doses
Inovio vaccine data published, US government invests to protect, generic remdesivir launched in Bangladesh.
You may also be interested in...
Multiple vaccine and drug developers across the world report progress and partnerships amid volatility in their shares.
Private Company Edition: Atea and Phlow receive big money for big COVID-19 problems – treatments and manufacturing capacity. Also, Cowen raises a $493m fund and antifungal developer Amplyx increases series C round to $90m, among other recent VC deals.
Vaccine manufacturing capacity has been lost in the UK in recent decades. Now a new Vaccines Manufacturing Innovation Centre will re-seed that capacity and expertise - and the pandemic is accelerating its arrival.